Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The potential role of testosterone in central serous chorioretinopathy.

Literature DB >> 17179128

The potential role of testosterone in central serous chorioretinopathy.

M C Grieshaber, J-J Staub, J Flammer.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2007 PMID： 17179128 PMCID： PMC1857578 DOI： 10.1136/bjo.2006.098277

Source DB: PubMed Journal: Br J Ophthalmol ISSN： 0007-1161 Impact factor: 4.638

× No keyword cloud information.

4 in total

1. Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants.

Authors: J M Zmuda; J A Cauley; A Kriska; N W Glynn; J P Gutai; L H Kuller
Journal: Am J Epidemiol Date: 1997-10-15 Impact factor: 4.897

2. Identification of androgen receptor protein and 5alpha-reductase mRNA in human ocular tissues.

Authors: E M Rocha; L A Wickham; L A da Silveira; K L Krenzer; F S Yu; I Toda; B D Sullivan; D A Sullivan
Journal: Br J Ophthalmol Date: 2000-01 Impact factor: 4.638

3. Association of stress, hostility and plasma testosterone levels.

Authors: Jean A King; Milagros C Rosal; Yunsheng Ma; George W Reed
Journal: Neuro Endocrinol Lett Date: 2005-08 Impact factor: 0.765

4. Elevated daytime urinary excretion of testosterone glucuronide in men with the type A behavior pattern.

Authors: B Zumoff; R S Rosenfeld; M Friedman; S O Byers; R H Rosenman; L Hellman
Journal: Psychosom Med Date: 1984 May-Jun Impact factor: 4.312

4 in total

19 in total

1. Finasteride for chronic central serous chorioretinopathy.

Authors: Farzin Forooghian; Annal D Meleth; Catherine Cukras; Emily Y Chew; Wai T Wong; Catherine B Meyerle
Journal: Retina Date: 2011-04 Impact factor: 4.256

2. Finasteride is effective for the treatment of central serous chorioretinopathy.

Authors: E Moisseiev; A J Holmes; A Moshiri; L S Morse
Journal: Eye (Lond) Date: 2016-04-08 Impact factor: 3.775

3. Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).

Authors: Timothy Y Y Lai; Raymond L M Wong; Wai-Man Chan
Journal: Trans Am Ophthalmol Soc Date: 2015

4. Thermal discomfort with cold extremities in relation to age, gender, and body mass index in a random sample of a Swiss urban population.

Authors: Maneli Mozaffarieh; Paola Fontana Gasio; Andreas Schötzau; Selim Orgül; Josef Flammer; Kurt Kräuchi
Journal: Popul Health Metr Date: 2010-06-04

5. The relationship between the central serous chorioretinopathy, choroidal thickness, and serum hormone levels.

Authors: Emine Çiloğlu; Fikret Unal; Nese Cetin Dogan
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2018-04-18 Impact factor: 3.117

6. Serum dehydroepiandrosterone sulphate, total antioxidant capacity, and total oxidant status in central serous chorioretinopathy.

Authors: Fatih Mehmet Türkcü; Harun Yüksel; Hatice Yüksel; Alparslan Sahin; Yasin Cinar; Abdullah Kürşat Cingü; Muhammed Sahin; Ihsan Caça
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2013-06-08 Impact factor: 3.117